ARTICLE
19 August 2017

Wellmark's Iowa ACA Exchange Exit Prompts Civil Rights Complaint

DP
Day Pitney LLP

Contributor

Day Pitney LLP logo
Day Pitney LLP is a full-service law firm with more than 300 attorneys in Boston, Connecticut, Florida, New Jersey, New York and Washington, DC. The firm offers clients strong corporate and litigation practices, with experience on behalf of large national and international corporations as well as emerging and middle-market companies. With one of the largest individual clients practices on the East Coast, the firm also has extensive experience assisting individuals and their families, fiduciaries and tax-exempt entities plan for the future.
An August 17 article in Bloomberg BNA's Privacy Law Watch and other publications, "Wellmark's Iowa ACA Exchange Exit Prompts Civil Rights Complaint," discussed an administrative complaint filed with the Department of Health and Human Services' Office for Civil Rights (OCR) by three groups representing hemophiliacs. Day Pitney's Eric Fader was quoted in the article.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

An August 17 article in Bloomberg BNA's Privacy Law Watch  and other publications, "Wellmark's Iowa ACA Exchange Exit Prompts Civil Rights Complaint," discussed an administrative complaint filed with the Department of Health and Human Services' Office for Civil Rights (OCR) by three groups representing hemophiliacs. Day Pitney's Eric Fader was quoted in the article.

The complaint claimed that Wellmark Blue Cross and Blue Shield's withdrawal from the Iowa health-insurance exchange, or marketplace, deprived hemophiliacs of coverage and violated the Affordable Care Act's nondiscrimination provision. Eric told Bloomberg BNA that the OCR might not act on the complaint because, while the ACA does bar insurers from denying coverage due to pre-existing conditions, it doesn't prevent insurers from deciding to stop offering plans altogether.
 
Eric also expressed doubt about the hemophilia groups' allegation that a Wellmark executive's statements had violated HIPAA, questioning whether referring to a 17-year old male hemophiliac was sufficient to allow anyone to identify the individual. "I don't understand why she [the executive] felt it necessary or appropriate to mention the patient's gender and precise age in her speech, but it doesn't appear to me that this was a clear HIPAA violation," Eric said. However, he did not rule out the idea that the OCR might use the incident as a teachable moment.


For more articles and regular updates on legislative changes, regulatory developments and other news of interest to businesses, professionals and investors in the healthcare industry, please subscribe to Day Pitney's mailing lists.


Click here for more Healthcare Blogs from Day Pitney

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More